U.S. market Closed. Opens in 1 hour 16 minutes

KZIA | Kazia Therapeutics Limited Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-30
Revenue555.0025.0015.18M1.06K1.56K13.11KN/AN/AN/AN/A1.07M1.51M2.02M9.91M11.15M13.28M17.31M13.50M17.61M16.35M32.93M19.59M58.91M26.75M19.32M
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.22M2.52M4.09M6.95M5.45M4.65M4.72M7.17M7.59M100.82M7.11M31.76M
Gross Profit555.0025.0015.18M1.06K1.56K13.11KN/AN/A89.00K87.00K1.11M1.51M2.02M7.69M8.62M9.19M10.36M8.06M12.96M11.62M25.76M12.01M-41.91M19.64M-12.43M
Operating Expenses24.12M24.88M24.13M13.16M10.25M14.69M10.35M12.77M8.14M6.40M3.11M11.19M13.46M22.92M32.40M35.02M37.38M30.36M25.13M24.01M36.26M31.01MN/A33.29M5.69M
Selling, General & Admin8.58M4.64M7.02M3.69M3.79M5.60M7.76M5.76M3.84M4.27M2.85M5.79M9.56M14.83M13.58MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Research & Development15.56M20.25M14.54M9.49M6.48M9.77M2.73M7.03M4.40M2.13M256.00K5.40M3.90M8.09M18.79M18.80M16.15M12.02M10.18M8.21M8.22M7.86MN/A5.93M3.60M
Other Operating Expenses-22.56K-10.00KN/A-22.00K-9.00K3.67M-137.00K-18.00K-99.00KN/AN/AN/AN/AN/A27.00K16.22M21.23M18.34M14.96M15.79M28.03M23.15MN/A27.37M2.10M
Operating Income-24.12M-26.70M-6.38M-12.53M-8.38M-12.49M-10.35M-12.77M-8.14M-6.40M-2.04M-9.68M-11.44M-15.23M-23.77M-25.83M-27.02M-22.30M-12.17M-12.39M-10.50M-19.00M-41.91M-13.66M-18.13M
Other Expenses / Income3.39M1.68M-2.53M-240.00K-2.19M8.22M-515.00K616.00K835.00K-1.17M531.00K937.00K494.00K-8.00K-11.00K1.07M2.69M4.39M-56.39KN/A78.66K4.38M-679.99KN/A599.21K
Before Tax Income-20.74M-25.02M-8.91M-12.77M-10.57M-6.34M-10.87M-12.15M-7.31M-7.57M-1.51M-8.74M-10.95M-15.24M-23.79M-24.76M-24.32M-17.92M-12.23MN/A-10.42M-14.62M-42.59M-13.66MN/A
Income Tax Expenses271.09K-368.08K484.35K-298.00K-298.00K-305.00K-199.00KN/AN/AN/AN/AN/A1.00K10.00K1.00K4.18K-1.18K1.35K2.62KN/A-7.42K44.41K58.79K21.77KN/A
Net Income-20.47M-24.65M-8.42M-12.47M-10.27M-6.04M-10.67M-12.06M-7.14M-7.47M-1.03M1.31M-6.50M-12.35M-18.93M-20.25M-20.00M-16.23M-12.23M-12.50M-10.41M-14.66M-42.65M-13.68M-17.08M
Interest ExpensesN/A2.09KN/AN/A2.19MN/A765.00KN/A69.00K715.00K132.00KN/A18.00K15.00K11.00K24.04K2.36K52.56K56.39K118.72KN/A344.58KN/AN/AN/A
Basic Shares Outstanding18.22M13.25M117.63M7.31M5.75M4.84M4.68M4.27M2.38M1.57M1.15M1.02M1.02M1.02M1.02M975.94K975.50K970.40K1.06M1.10M959.90K954.82K856.45K848.65K570.00K
Diluted Shares Outstanding18.43M13.25M117.67M7.31M5.75M4.84M4.68M4.27M2.38M1.57M1.15M1.02M1.02M1.02M1.02M975.94K999.88K970.40K1.06M1.10M959.90K954.82K856.45K848.65K570.00K
EBITDA-22.28M-24.74M-5.11M-11.44M-7.30M-17.69M-8.67M-11.72M-7.48M-5.74M-563.00K1.33M-6.40M-12.12M-18.63M-19.87M-19.03M-14.78M-10.55M-10.67M-8.54M-12.42M-42.59M-13.66M-15.73M
EBITDA Margin-4,013,885.95%-98,973,308.00%-33.68%-1,078,322.34%-466,198.08%-134,986.27%0.00%0.00%0.00%0.00%-52.76%88.17%-315.85%-122.35%-167.17%-149.68%-109.89%-109.46%-59.93%-65.30%-25.93%-63.39%-72.29%-51.06%-81.40%
EBIT-20.19M-25.01M-7.94M-12.77M-8.38M-6.34M-10.10M-12.06M-7.07M-6.75M-899.00K1.31M-6.48M-12.32M-18.92M-20.22M-20.00M-16.17M-12.17M-12.38M-10.42M-14.27M-42.59M-13.66M-17.08M
EBIT Margin-3,638,574.41%-100,055,204.00%-52.28%-1,203,110.27%-535,463.26%-48,397.92%0.00%0.00%0.00%0.00%-84.25%86.52%-319.95%-124.34%-169.70%-152.34%-115.53%-119.75%-69.13%-75.76%-31.65%-72.85%-72.29%-51.06%-88.37%
Financial Year End2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙